According to the latest report by IMARC Group, titled “Sterilization Services Market Report by Method (Ethylene Oxide Sterilization, Gamma Sterilization, Steam Sterilization, Electron Beam Radiation Sterilization, and Others), Type (Contract Sterilization Services, Sterilization Validation Services), Mode of Delivery (Off-Site Sterilization Services, On-Site Sterilization Services), End User (Hospitals and Clinics, Medical Device Companies, Pharmaceutical and Biotechnology Companies, and Others), and Region 2025-2033," the global sterilization services market size reached USD 4.0 Billion in 2024. Sterilization services refer to the process of eliminating microbial pathogens from the environment or surfaces. It includes various procedures, including steam, dry heat, chemical, radiation, filtration, and plasma sterilizations. These services are widely used by hospitals, clinics, biotechnology laboratories, medical equipment manufacturers, and pharmaceutical companies. They ensure the safety and efficacy of medical instruments, improve product service life, prevent contaminations, and minimize the risk of infections and disease transmission. Sterilization services also aid in promoting a healthy environment, ensuring regulatory compliance, and protecting the health of staff, workers, and patients.
Global Sterilization Services Market Trends:
The significant growth in the healthcare industry is one of the key factors creating a positive outlook for the market. Sterilization services are widely used by various healthcare facilities, such as hospitals, clinics, ambulatory surgical centers, nursing homes, rehabilitation centers, hospices, and diagnostic laboratories, to prevent disease transmission, reduce the risk of infection, and ensure the safety of medical equipment, surgical instruments, patient wards, and operating rooms (ORs). Furthermore, sterilization services are being widely adopted in the pharmaceutical industry to prevent sample contamination, ensure drug safety, and sterilize manufacturing equipment, storage facility, and various packaging, such as vials, ampoules, and syringes, which in turn is providing an impetus to the market growth. Additionally, the introduction of eco-friendly sterilization techniques, such as vaporized hydrogen peroxide (VHP), that do not generate toxic by-products and offers broad-spectrum anti-microbial properties against spores, mycobacteria, viruses, and fungi, is positively influencing the market growth. Moreover, the emerging trends of outsourcing sterilization services to access specialized expertise, reduce costs, and increase efficiency is propelling the market growth. Other factors, including rising incidences of healthcare-associated infections (HAI), increasing investment in the research and development (R&D) of advanced sterilization techniques, and growing consumer awareness regarding the importance of sterilization, are anticipated to drive the market growth. Looking forward, the market value is projected to reach USD 6.4 Billion by 2033, expanding at a CAGR of 5.14% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Method, Type, Mode of Delivery, End User, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | B. Braun Medical Ltd, Belimed AG (Metall Zug AG), BGS Beta-Gamma-Service GmbH & Co. KG, E-BEAM Services Inc, Fortive Corporation, Medistri SA, MMM Group, Noxilizer Inc., Sotera Health Company, Steris Corporation and Stryker Corporation. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800